
Pfizer CEO announces Omicron vaccine to be ready in March
Company is ‘already starting manufacturing some of these quantities at risk,’ top boss says

Pfizer Begins Making Shot That Targets Omicron, Original Virus
Pfizer Inc. is developing a hybrid vaccine that combines its original shot with a formulation that shields against the highly transmissible omicron variant, the drug giant’s top executive said.


Moderna to trial booster vaccine targeting Omicron variant
COVID news from January 10: Moderna CEO says Omicron-specific booster vaccine is about to enter clinical trials.